Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02403271
Title A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham Alabama 35294 United States Details
Scottsdale Arizona 85258 United States Details
La Jolla California 92093 United States Details
Los Angeles California 90025 United States Details
Los Angeles California 90048 United States Details
Palo Alto California 94305 United States Details
San Francisco California 94115 United States Details
Gainesville Florida 32610 United States Details
Orlando Florida 32806 United States Details
Chicago Illinois 60637 United States Details
Peoria Illinois 61615 United States Details
Hackensack New Jersey 07601 United States Details
Durham North Carolina 27710 United States Details
Germantown Tennessee 38120 United States Details
Nashville Tennessee 37212 United States Details
Houston Texas 77030 United States Details
San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field